Substrate Clearance Assay for Lysosomal Enzyme Potency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing the potency of lysosomal enzymes for enzyme replacement therapy in treating lysosomal storage diseases are inefficient, requiring extensive processing steps and lengthy hands-on time, and lack accuracy in measuring enzyme activity.
Innovation Solution
A substrate clearance assay platform combining physiological substrate cell assays with scintillation technology, where cells synthesize radiolabeled substrates and attach to a scintillant base, allowing for direct measurement of enzyme potency through reduced scintillation events after enzyme treatment, eliminating the need for trypsinization, centrifugation, and extensive wash steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional clearance assay methods are used, then enzyme potency can be measured, but extensive processing steps (trypsinization, centrifugation, wash steps) and lengthy hands-on time are required
Solution Approach 1:
The invention extracts and eliminates the繁琐 processing steps (trypsinization, centrifugation, wash steps) from the traditional assay protocol, retaining only the essential measurement function. By using adherent cells that remain attached to the plate bottom and a detection method that doesn't require cell detachment, the protocol removes multiple time-consuming operations while preserving the ability to measure enzyme potency accurately.
Solution Approach 2:
The invention uses radiolabeled substrates as a detectable copy or surrogate for the actual substrate accumulation. Instead of directly measuring substrate levels through complex processing, the radiolabeled analog provides a measurable signal that correlates with substrate clearance, enabling rapid assessment without extensive manual intervention.
2Measurement precision
If traditional clearance assay methods are used, then enzyme potency can be assessed, but the process requires multiple processing steps reducing throughput
Solution Approach 1:
The invention removes multiple processing steps (trypsinization, centrifugation, wash steps) from the traditional protocol, extracting only the essential measurement function. This streamlined approach maintains measurement precision while dramatically increasing throughput by eliminating bottlenecks in the workflow.
Solution Approach 2:
The invention merges the cell attachment function with the measurement function by using adherent cells that remain attached to the plate bottom during detection. This eliminates the need for separate cell detachment and processing steps, combining multiple operations into a single integrated assay format that increases productivity.
3Ease of operation
If radiolabeled substrates are used with cells attached to scintillant base, then direct measurement is possible, but cell attachment stability must be ensured
Solution Approach 1:
The invention uses adherent cells that naturally attach to the plate bottom through their own adhesion mechanisms, without requiring additional attachment steps or modifications. The cells serve themselves by maintaining attachment throughout the assay process, enabling direct measurement while ensuring reliability through their inherent adhesion properties.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces hands-on time, increases throughput, and provides a reliable, accurate, and efficient method for assessing enzyme potency, suitable for quality control, product standardization, and therapeutic monitoring.
Implementation Method 1
cells, particularly those that lack a relevant endogenous lysosomal enzyme, can synthesize a radiolabeled physiological substrate (e.g., GAGs) by, e.g., growing the cells at a desired cell density (e.g., about 80-98% confluent) in the presence of a radioactive isotope to be incorporated into the substrate (e.g., 35S)
Implementation Method 2
The radiolabeled substrate inside the cells is close enough to the scintillant base to emit electrons that cause scintillation events
Implementation Method 3
If the enzyme is potent (i.e., properly internalized, delivered to lysosomes and enzymatically active), the cells are able to metabolize accumulated substrates, resulting in degradation and release of radiolabels from the cells
Data Source
AI summary
The present invention provides, among other things, improved substrate clearance assays for lysosomal enzyme that are particularly useful for measuring potency of lysosomal enzymes or other therapeutics for treatment of lysosomal storage diseases. In particular, the present invention combines a physiologically relevant substrate cell assay and an efficient scintillation based detection method.